Resverlogix Honoured with World Economic Forum Technology Pio...(have made significant strides in improvi...)

Date:11/29/2007

have made significant strides in improving outcomes but are only able to address 30 percent of the risk associated with CVD. Consequently there exists a significant unmet medical need for a therapy to address the remaining 70 percent of risk. The proven ability of our drug to increase the production of ApoA-I and functional HDL, offers enormous potential to address this critical unmet need and impact the leading killer in the world".

The Technology Pioneers 2008 were nominated by the world's leading venture capital and technology companies. The final selection from 273 nominees was made by a panel of leading technology experts appointed by the World Economic Forum. To be selected as a Technology Pioneer, a company must be involved in the development of life-changing technology innovation and have potential for long-term impact on business and society. In addition, it must demonstrate visionary leadership, show the signs of being a long-standing market leader - and its technology must be proven. The award winners are companies that have been identified as developing and applying highly transformational and innovative technologies in the areas of energy, biotechnology and health, and information technology. Previous Technology Pioneers have included Business Objects, Gilead Sciences, Corel Corporation, Encore Software, Google, Mozilla Corporation and Napster.

Only one of the Technology Pioneers 2008 is based in Canada while 23 companies are US-based. Israel and Switzerland each boast three; the United Kingdom and Sweden two each; and France, Germany, India, the Netherlands and Russia, one each. Technology Pioneers are nominated in three main categories: Biotechnology/Health Energy/Environment, and Information Technology.

"This year the World Economic Forum received a record number of applications from companies around the world to become a Technology Pioneer. From a highly competitive field, we are extremely pleased to have a community that is usi
'/>"/>

SOURCE Resverlogix Corp. Copyright©2007 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5
Related biology technology :

1. Resverlogix Presents Key Apo-Al/HDL Scientific Data at DALM
2. Resverlogix is Presenting at IAS HDL Workshop
3. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
4. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
5. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
6. Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in Worlds Largest Stent Registry
7. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
8. Stereotaxis Niobe System Used to Perform More Than 10,000 Procedures Worldwide
9. NexGenix Pharmaceuticals Enters into Exclusive World-wide License to Develop Novel Hsp90 Inhibitors
10. PATH, World Health Organization, and Partners Introduce Meningitis Vaccine in Burkina Faso
11. Doping technique brings nanomechanical devices into the semiconductor world